Advanced search
Publication Cover
OncoTargets and Therapy Volume 9, 2016 - Issue
Submit an article Journal homepage
50
Views
6
CrossRef citations to date
0
Altmetric
Original Research

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy

Chunyu Wang1 Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
,
Xiaolong Fu3 Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
,
Xuwei Cai3 Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
,
Xianghua Wu4 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
,
Xichun Hu4 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
,
Min Fan1 Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
,
Jiaqing Xiang5 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
,
Yawei Zhang5 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
,
Haiquan Chen5 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
,
Guoliang Jiang1 Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Kuaile Zhao1 Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 117-122 | Published online: 30 Dec 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jianfeng Huang, Qinzhou Zou, Danqi Qian, Leyuan Zhou, Bo Yang, Jianjun Chu, Qingfeng Pang, Kewei Wang & Fuzheng Zhang. (2017) Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma. OncoTargets and Therapy 10, pages 5835-5841.
Read now

Articles from other publishers (5)

Jing Hu, Zhe Chen, Jiaming Lv, Zhen Zheng, Yanping Bei, Xue Chen, Lu Zheng, Wenjie Song & Yunbao Xu. (2022) The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study. Frontiers in Oncology 12.
Crossref
Mingbo Wang, Chao Huang, Wenda Gao, Yonggang Zhu, Fan Zhang, Zhenhua Li & Ziqiang Tian. (2022) MicroRNA-181a-5p prevents the progression of esophageal squamous cell carcinoma in vivo and in vitro via the MEK1-mediated ERK-MMP signaling pathway. Aging 14:8, pages 3540-3553.
Crossref
Saichun Qi, Ya Mao & Mingjun Jiang. (2019) A phase I study evaluating combined nimotuzumab and neoadjuvant chemoradiotherapy followed by surgery in locally advanced esophageal cancer. Cancer Chemotherapy and Pharmacology 84:5, pages 1115-1123.
Crossref
Azin Nahvijou, Mohamad Arab, Ahmad Faramarzi, Seyed Yaser Hashemi & Javad Javan-Noughabi. (2019) Burden of Esophageal Cancer According to World Health Organization Regions: Review of Findings from the Global Burden of Disease Study 2015. Health Scope 8:3.
Crossref
Wendy Bernhard, Ayman El-Sayed, Kris Barreto, Carolina Gonzalez, Wayne Hill, Angel Casaco Parada, Humphrey Fonge & C. Ronald Geyer. (2017) Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab . Oncotarget 9:5, pages 6213-6227.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.